Thus, this study aimed to perform molecular simulation studies of 17β-AEs with GPER1 and corroborate their proliferative actions in biological assays in breast and cervical cancer cell lines to assess whether these compounds represent potential therapeutic options in HRT for women in menopause, avoiding cancer cell development and proliferation. Here, GPER1 is linked to cancer.